A TNF-α inhibitor abolishes sepsis-induced cognitive impairment in mice by modulating acetylcholine and nitric oxide homeostasis, BDNF release, and neuroinflammation
Behavioural Brain Research · 2024-05 · 466 · 114995
DOI: 10.1016/j.bbr.2024.114995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2024-05. Verfasst von Mehmet Öz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Aksaray University, Aksaray, Turkiye. Electronic address: ozmhmt@gmail.com. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Brain-Derived Neurotrophic Factor, Nitric Oxide, Neuroinflammatory Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Aksaray University.
Themen: Sepsis
Abstract (Originalsprache)
Neurodegenerative disorders have a pathophysiology that heavily involves neuroinflammation. In this study, we used lipopolysaccharide (LPS) to create a model of cognitive impairment by inducing systemic and neuroinflammation in experimental animals. LPS was injected intraperitoneally at a dose of 0.5 mg/kg during the last seven days of the study. Adalimumab (ADA), a TNF-α inhibitor, was injected at a dose of 10 mg/kg a total of 3 times throughout the study. On the last two days of the experiment, 50 mg/kg of curcumin was administered orally as a positive control group. Open field (OF) and elevated plus maze tests (EPM) were used to measure anxiety-like behaviors. The tail suspension test (TST) was used to measure depression-like behaviors, while the novel object recognition test (NOR) was used to measure learning and memory activities. Blood and hippocampal TNF α and nitric oxide (NO) levels, hippocampal BDNF, CREB, and ACh levels, and AChE activity were measured by ELISA. LPS increased anxiety and depression-like behaviors while decreasing the activity of the learning-memory system. LPS exerted this effect by causing systemic and neuroinflammation, cholinergic dysfunction, and impaired BDNF release. ADA controlled LPS-induced behavioral changes and improved biochemical markers. ADA prevented cognitive impairment induced by LPS by inhibiting inflammation and regulating the release of BDNF and the cholinergic pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Aksaray University, Aksaray, Turkiye. Electronic address: ozmhmt@gmail.com.
- Department of Medical Genetics, Faculty of Medicine, Aksaray University, Aksaray, Turkiye.
Förderung
- Aksaray University
Zitieren
APA
Öz, M., & Erdal, H. (2024). A TNF-α inhibitor abolishes sepsis-induced cognitive impairment in mice by modulating acetylcholine and nitric oxide homeostasis, BDNF release, and neuroinflammation. Behavioural Brain Research, 466, 114995. https://doi.org/10.1016/j.bbr.2024.114995
Vancouver
Öz M, Erdal H. A TNF-α inhibitor abolishes sepsis-induced cognitive impairment in mice by modulating acetylcholine and nitric oxide homeostasis, BDNF release, and neuroinflammation. Behavioural Brain Research. 2024;466:114995. doi:10.1016/j.bbr.2024.114995
BibTeX
@article{z2024,
author = {Öz, Mehmet and Erdal, Hüseyin},
title = {A TNF-α inhibitor abolishes sepsis-induced cognitive impairment in mice by modulating acetylcholine and nitric oxide homeostasis, BDNF release, and neuroinflammation},
journal = {Behavioural Brain Research},
year = {2024},
volume = {466},
pages = {114995},
doi = {10.1016/j.bbr.2024.114995}
}
EUVIMED